Plasma levels of α 1 -antitrypsin-derived C-terminal peptides in PiMM and PiZZ COPD patients.

Friedemann R BörnerUrszula LechowiczSabine Wrenger Beatriz Martinez DelgadoBeata OlejnickaTobias Welte Joanna Chorostowska-WynimkoMichael KiehntopfSabina Janciauskiene

Published in: ERJ open research (2023)

Plasma levels of α 1 -antitrypsin-derived C-terminal peptides might be valid as novel biomarkers to predict and/or characterise exacerbations in PiMM and PiZZ COPD patients, or to reflect the efficiency of augmentation therapy in PiZZ patients https://bit.ly/3rNJeLd.

Keyphrases

end stage renal disease
newly diagnosed
chronic obstructive pulmonary disease
peritoneal dialysis
cystic fibrosis
lung function
air pollution